New Trial Targets Symptoms Beyond Obstruction
From Tales from the Heart by Hypertrophic Cardiomyopathy Association / Lisa Salberg
April 21, 2026 · 27 min · Season 6 · Episode 18
About this episode
Lisa Salberg and Dr. Ahmed Masri discuss the SONATA HCM clinical trial and its focus on targeting metabolism in heart treatment.
Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM. This conversation was recorded April 14, 2026
People in this episode
Host: Lisa Salberg
Guest: Dr. Ahmed Masri
Topics covered
- clinical trial
- hypertrophic cardiomyopathy
- patient participation
- metabolism
- treatment advancements
Keywords
- hypertrophic cardiomyopathy
- clinical trial
- SONATA HCM
- patient participation
- heart metabolism
Mentioned in this episode
Organizations: SONATA HCM
More episodes of Tales from the Heart
- Surgery, Science and HCM Success · June 8, 2026 · 1h 3m
- MRI Insights and HCM Risk · June 8, 2026 · 41 min
- India’s Growing HCM Awareness Movement · May 11, 2026 · 41 min
- SPECIAL REPORT: A Breakthrough for Non Obstructive HCM · May 6, 2026 · 58 min
- HCM Treatment Shifts and New Therapies · May 5, 2026 · 48 min
- Atrial Fibrillation Risk and New HCM Therapies · May 5, 2026 · 30 min
Explore listener stats, chart rankings, contacts and more on the Tales from the Heart podcast page.